Article Details
Retrieved on: 2023-11-15 21:48:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The Company is actively pursuing the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few ...
Article found on: www.bakersfield.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here